These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16208809)

  • 1. New test detects early prostate cancer.
    Health News; 2005 Sep; 11(9):9. PubMed ID: 16208809
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurement of prostate-specific antigen as a screening test for prostate cancer.
    N Engl J Med; 1991 Sep; 325(13):963-5. PubMed ID: 1715514
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Gamma-seminoprotein--a new tumour marker in prostatic cancer?
    Scheit KH
    Br J Urol; 1991 Sep; 68(3):331-2. PubMed ID: 1717099
    [No Abstract]   [Full Text] [Related]  

  • 4. [Early diagnosis of prostatic cancer in France in 1989].
    Küss R
    An R Acad Nac Med (Madr); 1990; Spec No():13-8. PubMed ID: 1702942
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood and serum substances for markers of prostate cancer.
    Bangma CH; Verhagen PC
    Microsc Res Tech; 2000 Dec; 51(5):430-5. PubMed ID: 11074613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotechnology. Researcher, two universities sued over validity of prostate cancer test.
    Kaiser J
    Science; 2009 Sep; 325(5947):1484. PubMed ID: 19762612
    [No Abstract]   [Full Text] [Related]  

  • 7. [The specific prostatic antigen: an element of diagnostic conflict?].
    Morote Robles J
    Med Clin (Barc); 1992 Apr; 98(15):598. PubMed ID: 1376383
    [No Abstract]   [Full Text] [Related]  

  • 8. Correspondence re: J. B. de Kok et al., DD3, A very sensitive and specific marker to detect prostate tumors. Cancer Res., 62: 2695-2698, 2002.
    Gandini O; Santulli M; Cardillo MR; Stigliano A; Toscano V
    Cancer Res; 2003 Aug; 63(15):4747; author reply 4748-9. PubMed ID: 12907658
    [No Abstract]   [Full Text] [Related]  

  • 9. A guide to a new prostate cancer tests.
    Johns Hopkins Med Lett Health After 50; 2014 May; 29(3):4-5. PubMed ID: 25097944
    [No Abstract]   [Full Text] [Related]  

  • 10. [After care of prostatic cancer].
    Ebert T
    Urologe A; 1992 Jul; 31(4):196-7. PubMed ID: 1381125
    [No Abstract]   [Full Text] [Related]  

  • 11. [Elevated PSA--what to do?].
    Machemer H; Rohde D
    MMW Fortschr Med; 2008 Oct; 150(44):38-9. PubMed ID: 19024490
    [No Abstract]   [Full Text] [Related]  

  • 12. The biochemical monitoring of prostate cancer. Yorkshire Regional Urological Cancer Research Group.
    Cooper EH; Armitage TG
    Prog Clin Biol Res; 1990; 357():23-7. PubMed ID: 1699238
    [No Abstract]   [Full Text] [Related]  

  • 13. Prediagnostic C-peptide and risk of prostate cancer.
    Borugian MJ; Spinelli JJ; Sun Z; Kolonel LN; Oakley-Girvan I; Pollak MD; Whittemore AS; Wu AH; Gallagher RP
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2164-5. PubMed ID: 17932367
    [No Abstract]   [Full Text] [Related]  

  • 14. [Early detection of prostatic cancer].
    Vallancien G
    Rev Prat; 1990 Jun; 40(17):1594-5. PubMed ID: 2194278
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of prostate specific antigen in early diagnosis of prostatic cancer].
    Xiao LP; Bi XJ; Li YN; Chen XQ; Zhang XF; Yu XP; Liu G; Yang MC; Song Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):107-8, 112. PubMed ID: 17259162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New markers and multivariate models for prostate cancer detection.
    Stephan C; Rittenhouse H; Cammann H; Lein M; Schrader M; Deger S; Miller K; Jung K
    Anticancer Res; 2009 Jul; 29(7):2589-600. PubMed ID: 19596933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond prostate-specific antigen: alternate serum markers.
    Ramírez ML; Nelson EC; Evans CP
    Prostate Cancer Prostatic Dis; 2008; 11(3):216-29. PubMed ID: 18227856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prostatic cancer--can unnecessary therapy be avoided? Prostate-specific antigens (PSA) kinetics can guide the management].
    Malmström PU
    Lakartidningen; 2006 Feb 1-7; 103(5):279. PubMed ID: 16512565
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum markers for prostate cancer: a rational approach to the literature.
    Steuber T; O'Brien MF; Lilja H
    Eur Urol; 2008 Jul; 54(1):31-40. PubMed ID: 18243505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate specific antigen and other markers for prostate cancer.
    Schröder FH
    J Urol; 2006 Apr; 175(4):1199-200. PubMed ID: 16515959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.